HeartSciences
HSCS
HeartSciences (HSCS) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Ascendiant Capital | Maintained | Buy | $8.00 from $9.20 | Mar 24, 2026 |
| Ascendiant Capital | Maintained | Buy | $9.20 from $9.00 | Dec 22, 2025 |
| Ascendiant Capital | Maintained | Buy | $9.00 from $15.00 | Oct 1, 2025 |
| Ascendiant Capital | Maintained | Buy | $14.00 from $15.00 | Mar 18, 2025 |
| Maxim Group | Maintained | Buy | $12.00 | Dec 18, 2024 |
| Ascendiant Capital | Maintained | Buy | $15.00 | Sep 23, 2024 |
Frequently asked questions
What is the latest analyst rating on HSCS?
On Mar 24, 2026, Ascendiant Capital maintained HeartSciences at Buy with a price target of $8.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.